January 7, 2020
Via: Market WatchBank of America expects European stocks broadly to rise this year, but its key underweight call is the pharmaceutical sector, and the recommendation has nothing to do with talk of reining in U.S. drug prices. Bank of America’s call on […]
March 8, 2019
Via: FortuneWith drug prices rising sitting at 10% of skyrocketing health care costs and pharmaceutical companies socking away big profits, you might assume that the U.S. has the highest prescription drug spending in the world. And you’d be right. Per capita […]